A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracyclines
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is
- To prevent progression of a lesion caused by anthracycline extravasation into necrosis,
which would require surgical intervention
- To prevent development of deep tissue necrosis and destruction leading to impaired limb
function and neurological deficit
- To prevent postponement of the scheduled cancer treatment due to the treatment of the
extravasation